Rectal cancer response to neoadjuvant chemoradiotherapy evaluated with MRI: Development and validation of a classification algorithm.
暂无分享,去创建一个
M. Rengo | A. Laghi | D. Caruso | D. Bellini | E. Iannicelli | V. Tombolini | I. Carbone | M. Osti | Stefano Badia | S. Picchia | F. Landolfi | Chiara Losquadro | Gaetano Giunta | G. Giunta
[1] E. Neri,et al. Radiomics and Magnetic Resonance Imaging of Rectal Cancer: From Engineering to Clinical Practice , 2021, Diagnostics.
[2] G. Russo,et al. Artificial intelligence applications in medical imaging: A review of the medical physics research in Italy. , 2021, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.
[3] R. Paramatti,et al. MR-based artificial intelligence model to assess response to therapy in locally advanced rectal cancer. , 2019, European journal of radiology.
[4] M. Scialpi,et al. Locally advanced rectal cancer: qualitative and quantitative evaluation of diffusion-weighted magnetic resonance imaging in restaging after neoadjuvant chemo-radiotherapy , 2019, Abdominal Radiology.
[5] R. Beets-Tan,et al. Response evaluation after neoadjuvant treatment for rectal cancer using modern MR imaging: a pictorial review , 2019, Insights into Imaging.
[6] European Society of Radiology. What the radiologist should know about artificial intelligence – an ESR white paper , 2019 .
[7] E. Medico,et al. Predicting locally advanced rectal cancer response to neoadjuvant therapy with 18F-FDG PET and MRI radiomics features , 2019, European Journal of Nuclear Medicine and Molecular Imaging.
[8] Yimin Liu,et al. Tumor volume predicts local recurrence in early rectal cancer treated with radical resection: A retrospective observational study of 270 patients. , 2018, International journal of surgery.
[9] Stuart A. Taylor,et al. Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting , 2017, European Radiology.
[10] Damiano Caruso,et al. Magnetic resonance tumor regression grade (MR-TRG) to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer , 2017, Oncotarget.
[11] Gina Brown,et al. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales , 2016, World journal of gastroenterology.
[12] Gina Brown,et al. Magnetic Resonance Tumor Regression Grade and Residual Mucosal Abnormality as Predictors for Pathological Complete Response in Rectal Cancer Postneoadjuvant Chemoradiotherapy , 2016, Diseases of the colon and rectum.
[13] P. Tekkis,et al. Interobserver agreement of radiologists assessing the response of rectal cancers to preoperative chemoradiation using the MRI tumour regression grading (mrTRG). , 2016, Clinical radiology.
[14] L. Raffaele,et al. Locally advanced rectal cancer: Qualitative and quantitative evaluation of diffusion-weighted MR imaging in the response assessment after neoadjuvant chemo-radiotherapy , 2016, European journal of radiology open.
[15] E. Neri,et al. MRI tumor volume reduction rate vs tumor regression grade in the pre-operative re-staging of locally advanced rectal cancer after chemo-radiotherapy. , 2015, European journal of radiology.
[16] G. Beets,et al. Prospective, Multicenter Validation Study of Magnetic Resonance Volumetry for Response Assessment After Preoperative Chemoradiation in Rectal Cancer: Can the Results in the Literature be Reproduced? , 2015, International journal of radiation oncology, biology, physics.
[17] Levente Kovács,et al. Tumor Volume Estimation and Quasi-Continuous Administration for Most Effective Bevacizumab Therapy , 2015, PloS one.
[18] L. Stassen,et al. Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment , 2015, Annals of Surgical Oncology.
[19] Y. Huang,et al. Tumor volume reduction rate is superior to RECIST for predicting the pathological response of rectal cancer treated with neoadjuvant chemoradiation: Results from a prospective study. , 2015, Oncology letters.
[20] J. Gu,et al. Tumor regression grades: potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy. , 2015, World journal of gastroenterology.
[21] Karin Haustermans,et al. EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum. , 2014, European journal of cancer.
[22] M. Kim,et al. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. , 2012, The British journal of radiology.
[23] G. Beets,et al. T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer , 2012, European Radiology.
[24] Gina Brown,et al. Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Tae Hyun Kim,et al. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. , 2010, International journal of radiation oncology, biology, physics.
[26] A. Crucitti,et al. Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.
[27] J. Lim,et al. Tumor volume changes assessed by three-dimensional magnetic resonance volumetry in rectal cancer patients after preoperative chemoradiation: the impact of the volume reduction ratio on the prediction of pathologic complete response. , 2010, International journal of radiation oncology, biology, physics.
[28] G. Beets,et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? , 2009, Radiology.
[29] Muhammad Zubair Shafiq,et al. Guidelines to Select Machine Learning Scheme for Classification of Biomedical Datasets , 2009, EvoBIO.
[30] E. Rummeny,et al. Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens. , 2006, Radiology.
[31] Tae Hyun Kim,et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. , 2005, International journal of radiation oncology, biology, physics.
[32] Fábio Guilherme Campos,et al. Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.
[33] James R. Dixon,et al. The International Conference on Harmonization Good Clinical Practice guideline. , 1999, Quality assurance.
[34] J. Petiot,et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.